Hot off the breath: Mortality as a primary end-point in IPF treatment trials: The best is the enemy of the good

Athol U. Wells, Juergen Behr, Ulrich Costabel, Vincent Cottin, Venerino Poletti, Luca Richeldi, C. Albera, J. Ancochea, K. M. Antoniou, P. Bonella, D. Bouros, P. Bresser, J. F. Cordier, B. Crestani, J. Domagala-Kulawik, M. Drent, J. J. Egan, T. Geiser, J. Grunewald, J. GruttersG. Gudmundsson, A. Guenther, S. Harari, N. K. Harrison, N. Hirani, U. Hodgson, C. M. Kahler, M. P. Keane, G. Kiter, M. Kneussl, T. M. Maher, N. Mogulkoc, J. Muller-Quernheim, C. Neurohr, H. Nunes, H. Parfrey, T. Peros-Golubicic, V. Polychronopoulos, G. Prevot, E. R. Renzoni, C. Robalo Cordeiro, C. Saltini, M. Skold, P. Spagnolo, M. Thomeer, S. Tomasseti, D. Valeyre, C. Vancheri, B. Wallaert, W. Wuyts, A. Xaubet

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish
Pages (from-to)938-940
Number of pages3
Issue number11
Publication statusPublished - Nov 1 2012

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this